Skip to main content

Pressmeddelanden 1 träff

Sanofi Compounds to be Featured in 178 Abstracts at American Society of Hematology Annual Meeting

Pressmeddelanden   •   Dec 03, 2012 10:24 CET

Sanofi announced today that new research spanning the company’s marketed and investigational hematology products, including its late-stage selective JAK2 inhibitor, will be featured in 178 abstracts to be presented at the 2012 Annual Meeting of the American Society of Hematology in Atlanta, GA., December 8-11, 2012.